Evidence map›Paper›PMID 20561719›Full record

ArticleAtencion primaria2011

[Plan for improving pharmacy indicators in a primary health area of Madrid. Description and results].

José Manuel Izquierdo-Palomares, María José Almodóvar Carretón, Luís Carlos Saiz Fernández, Raquel Siguín Gómez, Carlos López Gómez, Sofía Garrido Elustondo

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Atencion primaria, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

José Manuel Izquierdo-PalomaresServicio de Farmacia, Atención Primaria, Madrid, España. farmac.gapm07@salud.madrid.org
María José Almodóvar Carretón
Luís Carlos Saiz Fernández
Raquel Siguín Gómez
Carlos López Gómez
Sofía Garrido Elustondo
Madrid Health Service · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the results of a plan for improving pharmacy indicators in a Primary Care (PC) Health Area.

designQuasi-experimental study with a control group. The differences between the pre-intervention (Jan-Dec 2007) and post-intervention (Jan-Dec 2008) periods were evaluated. SETTING AND

participantsIntervention group: Primary Care doctors from PC Area 7 of the Community of Madrid (n=397). CONTROL GROUP: the rest of PC doctors of the Community of Madrid (n=4428).

methodA multi-focus plan in which the main activities were: sessions in the health centres with the worst results, involvement of those responsible for the Rational Use of Drugs, interviews with the doctors with the most improvable indicators, recognition of those with good indicators, and preparing short notes on drugs. MAIN MEASUREMENTS: Prescription and notification indicators associated with the safety of drugs.

resultsIn relation to Madrid, the absolute improvements of Area 7 in the accumulated indicators, %Generic drugs, %Statins, %ARAII y %Omeprazole were 0.29; 1.17; 0.61 and 0.37 percentage points, respectively. DHD Osteoporosis equalled the improvement of Madrid. In Area 7, the increase in notifications of suspected serious ADRs was 180% and number of ADR notifications of ADRs was 233%, better than the Madrid data (48% and 21%). The notification of medication errors showed similar increases in both groups (PC Area 7 1567% vs. Madrid PC 1633%).

conclusionsImplementing a multi-focus improvement plan with feasible and specific actions can be a useful tool for improving pharmacy indicators.

Indexed as

Primary Health CareQuality Indicators, Health CarePharmaceutical ServicesPlanning TechniquesSpainUrban Health

Identifiers

PMID20561719
PMCPMC7025068
OpenAlexW2171406993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.